Clinical trial
A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After…
NCT00439881 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00439881 |
|---|---|
| Title | A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single Dose |
| Official title | A Study to Assess the Safety and Tolerability of SB-681323 Administered Via the Intravenous Route |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid, Inflammation |
| Intervention type | Drug |
| Interventions | SB-681323 |
| Enrollment | 16 |
| Start date | Oct 1, 2006 |
| First posted | Feb 26, 2007 |
| Last update posted | Jun 4, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: